pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
RABI-767
Pancreatitis
Lamassu Pharma LLC
0
catalysts
Phase 2
RAGE Inhibitor
Coronavirus Disease 2019 (COVID-19)
Galactica Pharmaceuticals Inc
0
catalysts
Phase 2
RAP-219
Bipolar I Disorder
$RAPP
Rapport Therapeutics, Inc.
0
catalysts
Phase 2
RAPA-201
Refractory Multiple Myeloma
← prev
page 23 of 50
next →
131
Pain
89
Neurology
1
Rapa Therapeutics LLC
0
catalysts
Phase 2
RB-601
Head And Neck Cancer
Radiance Biopharma Inc
0
catalysts
Phase 2
RCT-2100
Cystic Fibrosis
Recode Therapeutics Inc
0
catalysts
Phase 2
RD-1302
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Imviva Biotech
0
catalysts
Phase 2
REC-1245
Lymphoma
$RXRX
RECURSION PHARMACEUTICALS, INC.
0
catalysts
Phase 2
REC-4881
Familial Adenomatous Polyposis
Dual specificity mitogen-activated protein kinase kinase 1
Dual specificity mitogen-activated protein kinase kinase 2
$RXRX
RECURSION PHARMACEUTICALS, INC.
0
catalysts
Phase 2
REGV-131
Hemophilia B (Factor IX Deficiency)
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Phase 2
REM-422
Adenoid Cystic Carcinoma (ACC)
Remix Therapeutics Inc
0
catalysts
Phase 2
REVTX-300
Chronic Kidney Disease (Chronic Renal Failure)
$REVB
REVELATION BIOSCIENCES, INC.
0
catalysts
Phase 2
RG-6351
Diabetic Macular Edema
Genentech Inc
0
catalysts
Phase 2
RG-6596
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 2
RG-6794
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Genentech Inc
0
catalysts
Phase 2
RGI-2001
Graft Versus Host Disease (GVHD)
REGiMMUNE Ltd
0
catalysts
Phase 2
RIV3 + rC19
Coronavirus Disease 2019 (COVID-19)
$SNY
Sanofi
0
catalysts
Phase 2
RLF-TD011
Dystrophic Epidermolysis Bullosa
$RLFTY
MindMaze Therapeutics Holding SA
0
catalysts
Phase 2
RLS-1496
Actinic (Solar) Keratosis
Rubedo Life Sciences Inc
0
catalysts
Phase 2
RM-718
Obesity
$RYTM
RHYTHM PHARMACEUTICALS, INC.
0
catalysts
Phase 2
RN-0361
Familial Chylomicronemia (Type I Hyperlipoproteinemia)
Rona Therapeutics Inc
0
catalysts
Phase 2
RNDP-001
Parkinson's Disease
Kenai Therapeutics Inc
0
catalysts
Phase 2
RNK-05047
Diffuse Large B-Cell Lymphoma
Ranok Therapeutics Co Ltd
0
catalysts
Phase 2
RNS-60
Acute Ischemic Stroke
Revalesio Corp
0
catalysts
Phase 2
RP-323
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
PhorMed Inc
0
catalysts
Phase 2
RPA-501
Glycogen Storage Disease (GSD)
$RCKT
ROCKET PHARMACEUTICALS, INC.
0
catalysts
Phase 2
RPESCRPE-4W
Dry (Atrophic) Macular Degeneration
Luxa Biotechnology LLC
0
catalysts
Phase 2
RSLV-132
Post-Acute Sequelae of COVID 2019 (PASC or Long COVID)
Resolve Therapeutics LLC
0
catalysts
Phase 2
RT-100
Systolic Heart Failure (HFrEF)
Renova Therapeutics Inc
0
catalysts
Phase 2
RV-01
Castration-Resistant Prostate Cancer (CRPC)
Radiopharm Ventures LLC
0
catalysts
